Texas Capital Bancshares 5.75% Dep Shares Non-Cumulative Perp Prfd Stock, Ser B (TCBIO)
NGS · Preferred · CUSIP 88224Q305
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for TCBIO and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Details

Coupon Rate
5.75%
Liquidation Preference
$25.00
Call Price
$25.00
Call / Redemption Date
6/15/2026
Maturity Date
None
Distribution Period
Q
Rate Type
Fixed
Annual Distribution
1.4375
Distribution Dates
3/15, 6/15, 9/15 & 12/15
Credit Ratings
Moody's Ba2 · S&P BB- (12/31/2023)
Tax-Advantaged Dividends
Yes

Security Profile

Security Type
Traditional Preferred Stock »
CUSIP
88224Q305
Market Cap
Small Cap
IPO
2/24/2021 · $25.00/share
Previous Symbol
TCBLL (changed 3/26/2021)
Parent Company
Texas Capital Bancshares (TCBI)
Business: Texas Capital Bancshares Inc, 5.75% Depositary Shares each representing a 1/40th interest in a share of the Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series B, liquidation preference $25 per Depositary share, redeemable at the issuer's option on or after 06/15/2026 at $25 per Depositary share plus declared and unpaid dividends, and with no stated maturity. <p> Cumulative distributions of 5.75% per annum ($1.4375 per annum or $0.359375 per quarter) will be paid quarterly on 3/15, 6/15, 9/15 & 12/15 to holders of record on the record date that shall be the 15th calendar day prior to the payment date (NOTE: the ex-dividend date is one business day prior to the record date). Dividends paid by this preferred security are eligible for the preferential income tax rate of 15% to a maximum of 20% depending on the holder's tax bracket (and under IRS specified holding restrictions) and are also eligible for the dividends received deduction for corporate holders (see page S-33 of the prospectus for further information). <p> This security is possibly subject to an early call as a result of the occurrence of a regulatory capital treatment event which no longer allows the company to include the funds originating from this security as Tier 1 capital on their balance sheet (see the prospectus for further information). <p> This security was rated as Ba2 by Moody’s and B+ by S&P at the date of its IPO. In regard to the payment of dividends and upon liquidation, the preferred shares rank junior to the company's senior debt, equally with other preferreds of the company, and senior to the common shares of the company. See the IPO prospectus for further information on the preferred stock by clicking on the ‘Link to IPO Prospectus’ provided below.
Notes: The 5.75% Series B preferred shares were issued on 02/24/2021 and started trading temporarily on the Other OTC market 02/24/2021 under the ticker symbol TCBLL until they start trading on the Nadaq Global Select Market. The shares are expected to start trading on the Nasdaq within 30 days of their issue date under their permanent ticker symbol of TCBIO. For information on securities trading on the Other OTC, see our discussion on this subject on our What Income Investors Should Know page which can be found on our Information menu at the top of any page.

Company Contact

CEO
Rob C. Holmes
CFO
Julie L. Anderson
Headquarters
2000 McKinney Avenue, Suite 700, Dallas, TX 75201
Phone
214-932-6600 · Toll-Free 877-839-2265
Fax
214-932-6604
Investor Relations
Jamie Britton · 214-932-6721 · Jamie.Britton@texascapitalbank.com
Email Form
Request Form »
SEC EDGAR Filings
View filings »